Cotización California BanCorp - BCAL | ADVFN

US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
California BanCorp (BCAL) Cotización

California BanCorp (BCAL)

16.27

0.84

(5.44%)

Al cierre: 29 Enero 3:00PM

Delayed by 15 minutes

16.27

0.10

( 0.62% )

Fuera de horario: 4:30PM

Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Último Precio

16.27

Postura de Compra

6.54

Postura de Venta

18.00

Volume Operado de la Acción

160,178

15.48 Rango del Día 16.50

12.30 Rango de 52 semanas 18.49

Precio Anterior

15.43

Precio de Apertura

15.51

Hora

Última hora de negociación

15:08:45

Volumen promedio (3 m)

64,173

Volumen financiero

US$ 2,582,159

Precio Promedio Ponderado

16.1206

CALIFORNIA BANCORP REPORTS NET INCOME OF $16.8 MILLION FOR THE FOURTH QUARTER AND $5.4 MILLION FOR THE FULL YEAR OF 2024

San Diego, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- California BanCorp (“us,” “we,” “our,” or the “Company”) (NASDAQ: BCAL), the holding company for California Bank of Commerce, N.A. (the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

California Bank of Commerce Names Jerry Legg Director of Public Sector Banking

San Diego, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- California Bank of Commerce, N.A. (the “Bank”), the wholly owned subsidiary of California BanCorp (Nasdaq: BCAL), announces the appointment...

Form 8-K - Current report

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	1.17	7.74834437086	15.1	16.27	14.8	40003	15.21133442	CS
4	-0.39	-2.34093637455	16.66	16.78	14.7	57690	15.34377445	CS
12	0.27	1.6875	16	18.49	14.7	64173	16.75047925	CS
26	1.32	8.82943143813	14.95	18.49	12.47	71515	15.45956824	CS
52	-0.44	-2.63315380012	16.71	18.49	12.3	60641	15.00622883	CS
156	3.02	22.7924528302	13.25	18.49	12.3	44713	15.08343901	CS
260	3.02	22.7924528302	13.25	18.49	12.3	44713	15.08343901	CS

BCAL - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de California BanCorp?

El precio actual de las acciones de California BanCorp es US$ 16.27

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de California BanCorp?

California BanCorp ha negociado en un rango de US$ 12.30 a US$ 18.49 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
PCSAProcessa Pharmaceuticals Inc	US$ 0.8023 (35.46%)	2.26M
CARMCarisma Therapeutics Inc	US$ 0.6498 (28.75%)	4.33M
SPGCSacks Parente Golf Inc	US$ 0.7513 (27.34%)	2.1M
HUBCWHub Cyber Security Ltd	US$ 0.037 (23.33%)	100
IVAInventiva SA	US$ 2.68 (16.52%)	23.09k
CRGXCARGO Therapeutics Inc	US$ 2.9901 (-77.33%)	4.65M
SLXNSilexion Therapeutics Corporation	US$ 2.21 (-29.62%)	8.37M
IKTInhibikase Therapeutics Inc	US$ 2.2001 (-21.43%)	303.86k
IRWDIronwood Pharmaceuticals Inc	US$ 3.08 (-17.20%)	47.24k
DWSNDawson Geophysical Company	US$ 1.20 (-14.29%)	687
NVDANVIDIA Corporation	US$ 122.32 (-1.12%)	41.59M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 27.07 (9.46%)	22.21M
TSLATesla Inc	US$ 407.27 (4.67%)	17.63M
PLUGPlug Power Inc	US$ 1.87 (-0.53%)	9.9M
VCSHVanguard Short Term Corporate Bond	US$ 78.41 (0.00%)	9.57M

Backstabbed

Backstabbed 5 minutos hace

25,000 shares x $0.20 = $5,000 USD

newmedman

newmedman 5 minutos hace

Hold on to the truth…
A recording from Jim Acosta's Substack live video
JIM ACOSTA
JAN 28, 2025
It was early March in 2007 when I received a phone call in the middle of the night. CNN’s bureau chief in New York at the time, Edith Chapin, called to deploy me to the Bronx o

MartinLutherKing

MartinLutherKing 5 minutos hace

https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors?

valuemind

valuemind 5 minutos hace

2025-2027 will be TSLA years!

jondoeuk

jondoeuk 6 minutos hace

The PR is an utter mess! The ORR across subgroups is higher, but the (m)PFS isn't that great.

MartinLutherKing

MartinLutherKing 6 minutos hace

FDA Approves TransCode's Phase 1/2 Trial of TTX-MC138 for Advanced Solid Tumors
18 April 2024
3 min read
TransCode Therapeutics, Inc., a specialist in RNA oncology, has revealed that the U.S. Food and Drug Administration has finished reviewing their Investigational New Drug appl

Backstabbed

Backstabbed 7 minutos hace

50,000 shares x $0.20 = $10,000 USD

Backstabbed

Backstabbed 8 minutos hace

100,000 shares x $0.20 = $20,000 USD

Backstabbed

Backstabbed 8 minutos hace

250,000 shares x $0.20 = $50,000 USD

ChartTRACKER

ChartTRACKER 8 minutos hace

$ADTX: Lay off the Kool-aid buddy!
250:1 😂 ! [You go that wrong too! You post is showing as a F/S]!!

A Company needs to maintain > 500k Shs to be listed on NASDAQ after a R/S.

Backstabbed

Backstabbed 8 minutos hace

500,000 shares x $0.20 = $100,000

Techroemancer

Techroemancer 8 minutos hace

Hopefully the momentum of the volume will continue to uptick. With the current O/S, we need some big volume days to get us out of the trips land. The financials and performance are phenomenal and once we can gain some traction/momentum, this should be easy to launch. Just need the interest/volume an

MartinLutherKing

MartinLutherKing 9 minutos hace

TTX-MC-138 targets miR-10b and has potential applications in the treatment of various cancers and diseases affecting different body systems. The drug is currently in Phase 1/2 of development and has been designated as an orphan drug, indicating its potential to address unmet medical needs in rare di

zab

zab 9 minutos hace

Trump's pandemic killed 1.3 million Americans, you must be so happy with his choice to downplay it.

Backstabbed

Backstabbed 9 minutos hace

1,000,000 shares x $0.20 = $200,000 USD

Backstabbed

Backstabbed 9 minutos hace

Cohen said $0.20 by May 2025! $ZHUD

stealofadeal

stealofadeal 9 minutos hace

$KRTL Another good day today. Thin share structure and going to move fast.

bb8675309

bb8675309 10 minutos hace

Hey Bourbon. Good to hear from you. Yes, it would be great if they brought back the uptick rule. Might help. Maybe that's the way market shorting was once done and is intended to work but today shorts are destroying good companies. I don't believe the retail investor has SEC protection in the market

Whalatane

Whalatane 10 minutos hace

Ha ha ...hope not . Usually analysts give 1 yr targets
Co will be hosting a commercialization day this Qt I think ...to show they are ready to launch as soon as approved
Kiwi

Ex-brokerBry

Ex-brokerBry 10 minutos hace

Ok Georgie18,do you have any idea who that seller is.?When will this end.Stocks have a tendency to go down slowly and then rise guickly.My Morgan Stanley has a final price after that 1 milly buy at the end at .0457....I've been burned with these kind of stocks.If it drops below .03 I'm buying more.Y

jondoeuk

jondoeuk 10 minutos hace

We won't know until it is tested, but from this: 'We found activated CD19 CAR.ADR T cells have lower levels of detectable 4-1BB on their surface compared to CD19 CAR T cells, suggesting partial downregulation or masking of 4-1BB upon ADR expression (Supplementary Fig. 9a). Indeed, expression of a tr

nowwhat2

nowwhat2 11 minutos hace

What a performance eh ?.......How's about THAT ?

https://investorshub.advfn.com/uimage/uploads/2025/1/29/bghbxBTC_!_29_15d_930am_fomc_deep_import.jpg

https://investorshub.advfn.com/uimage/uploads/2025/1/29/ipgjvbtc_!_29_15d_2pm_FOMC_update_100k.jpg

valuemind

valuemind 11 minutos hace

NXT outperformed FSLR nearly 50% in the past 3 months. Stock selection is apparently more important than industry selection.

California BanCorp

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones